Paras Healthcare IPO — GMP Today, Price Band & Dates

Paras Healthcare
GMP ▲ 13
Closed
Date21-23 Oct 2026
IPO Price: ₹693
Est. Listing: ₹706 (1.88%)
Type: Mainboard

Paras Healthcare IPO GMP Today

The current grey market premium (GMP) of the Paras Healthcare IPO is ₹13. GMP reflects unofficial demand for the shares before listing and moves with market sentiment and subscription numbers. This figure updates automatically every hour.

Key Details

IPO NameParas Healthcare
TypeMainboard
IPO Dates21-23 Oct 2026
Price Band₹693
GMP Today₹13
Estimated Listing₹706 (1.88%)
StatusClosed

Live data last refreshed: 16/11/2026, 17:26:32 IST

FAQ

What is the GMP of Paras Healthcare IPO today?

Paras Healthcare IPO GMP today is ₹13.

What are the Paras Healthcare IPO dates?

Paras Healthcare IPO dates: 21-23 Oct 2026.

Is Paras Healthcare a Mainboard or SME IPO?

Paras Healthcare is a Mainboard IPO.

Does GMP guarantee listing gains?

No. GMP is an unofficial, unregulated indicator and can change quickly. Always evaluate the company's fundamentals before investing.

About Paras Healthcare

Paras Healthcare Limited is a clinical specialty-led healthcare provider offering tertiary and quaternary healthcare services under the 'Paras Health' brand. The company operates a network of eight hospitals across North India, Bihar, and Jharkhand, with its oldest hospital in Gurugram operating for 20 years. As of June 30, 2026, the company had an aggregate bed capacity of 2,211 beds, 1,502 operational beds, and 559 ICU beds. Its network spans Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi, and Srinagar, supported by 1,084 doctors and 1,937 nurses.

Business Model

Paras Healthcare operates under a single business segment of healthcare services. It generates revenue primarily through in-patient department (IPD) services, out-patient department (OPD) consultations, and pharmacy sales. In Fiscal 2026, in-patient revenue contributed the majority of operational revenue. The company serves patients across three payor categories: government schemes and public sector undertakings (41.28% of Fiscal 2026 revenue), self-pay patients (33.88%), and insurance/third-party administrators (24.84%).

Financial Performance

MetricFiscal 2024Fiscal 2025Fiscal 2026
Revenue from operations₹ 11,290.39 million₹ 12,940.63 million₹ 16,059.52 million
EBITDA₹ 1,544.11 million₹ 1,564.61 million₹ 3,355.77 million
EBITDA margin (%)13.42%11.91%20.60%
Profit / (loss) after tax₹ (153.31) million₹ (579.83) million₹ 438.34 million
Net profit margin (%)(1.33)%(4.41)%2.69%
Net worth₹ 3,385.08 million₹ 2,804.92 million₹ 3,949.41 million
Total borrowings₹ 5,475.33 million₹ 7,279.31 million₹ 8,541.01 million

Figures as disclosed in the DRHP/RHP filed with the stock exchange. Source: offer document.

Objects of the Issue

Promoters

Dr. Dharminder Kumar Nagar is the Promoter and Managing Director. Associated with the company since 2003, he has over 22 years of healthcare industry experience and holds MBBS and MPhil degrees. He holds 73,519,238 equity shares (72.80% pre-Offer).

Strengths

Key Risks

Points to Weigh

This page is updated automatically as the IPO progresses — price band, dates and live GMP appear above once announced. Nothing here is investment advice.